ATOM vs DRUG vs MVB — overlap, fees and exposure compared

ATOM, DRUG and MVB hold at least 115 companies between them. None is in every one of them, and ATOM and DRUG are the most alike: 0% of each is the same companies.

Side by side

ATOM DRUG MVB

FundGlobal XBetaSharesVanEck

Asset classSector & thematicSector & thematicSector & thematic

Fee a year0.69%0.57%0.28%

Fund size$152.0m$163.0m$279.0m

Holdings58668

1Y price return−32.1%+6.6%−5.0%

Distribution yield9.28%3.91%4.53%

Look-through coverage90.5%99.7%100.0%

Return, last year

change since the start

share of each fund

ATOM
DRUG
MVB

CCO CAMECO CORPIn 1 of 3ATOM22.0%DRUGnot heldMVBnot held
ANZ ANZ GROUP HOLDINGS LIMITEDIn 1 of 3ATOMnot heldDRUGnot heldMVB20.7%
NAB NATIONAL AUSTRALIA BANK LIMITEDIn 1 of 3ATOMnot heldDRUGnot heldMVB20.2%
WBC WESTPAC BANKING CORPORATIONIn 1 of 3ATOMnot heldDRUGnot heldMVB20.2%
CBA COMMONWEALTH BANK OF AUSTRALIA.In 1 of 3ATOMnot heldDRUGnot heldMVB19.2%

and 105 more companies the funds hold

How alike they are

Keep going

See ATOM + DRUG + MVB as one portfolioEvery company, where you'd own it twice What moved ATOM this monthIts biggest gains and falls, by company